NCT05541003View on ClinicalTrials.gov

Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

May 29, 2023

Study Completion Date

May 30, 2023

Conditions
Prader-Willi SyndromeObesity
Interventions
DRUG

NBT-NM108

All patients will consume NBT-NM108 in the form of 2 muffins daily.

Trial Locations (1)

08901

Robert Wood Johnson University Hospital, New Brunswick

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER